HMGB1 activated the MEK/ERK signal to promote the expression of inflammatory factors, and an HMGB1 neutralizing antibody inhibited the expression of ICAM‐1 in an ATRA‐treated DS mouse model and reduced mortality.188. This evidence concerns the gene HMGB1 and Dravet syndrome.